Multi-Site Coordination Demo

—

Coordinated decisions

—

Enrollments gained

—

Conflicts avoided

—

Screen-fail reduction

Trial & Site Network

3 concurrent trials running across shared sites — with patient eligibility overlapping across protocols.

Trials

Phase II NSCLC ADC

Target N: 80 · 18-month window
Indication: Non-small cell lung (ADC)

Phase III Breast HER2-low

Target N: 240 · 30-month window
Indication: Breast cancer (HER2-low)

Phase II Rare CGT

Target N: 40 · 24-month window
Indication: Cell & gene therapy (rare)

Sites

Patient Pool

400

Total Patients

— patients eligible for 2+ trials.
Siloed outreach would contact them multiple times — wasted touches, patient frustration, potential dropout.

Metric

Per-Trial Siloed

Syncra Coordinated

Total outreach contacts sent

—

Duplicate patient contacts

—

0 avoided

Sites over capacity

—

Eligible patients prioritized

—

Projected enrollments (90-day)

—

Unnecessary screen-fails

—

CRC hours saved

—

Avoided Contact Conflicts

Multi-Trial Priority Assignments

Site Capacity Rebalancing

Siloed: each trial runs outreach independently, blowing past capacity at shared sites. Coordinated: Syncra rebalances allocation to stay within ceilings.

Ready to see this on your actual portfolio?

Book a 20-minute walkthrough — we'll map your active trials against your site network and show you the coordination gaps in real data.

Book 20-min walkthrough → Try Risk Scorer Protocol Change Demo